Apple is going fully solar in Singapore.
This may sound like old news, seeing as Apple already has solar-powered stores in the U.S. and China, along with several other locations. This move, however, is unique due to the fact that its new stores in Singapore will be the first solar powered store in all of southeast Asia.
To make this possible, Apple partnered with Singapore’s largest clean energy provider to supply the power for the solar panels on roughly 800 structures, which in turn will supply 40 gigawatt-hours of power for both the new Apple store, as well as its corporate campus.
This company will also most likely supply power for Apple’s new buildings that are launching next year.
Something worth noting, however, is that even though Apple is going to support these new branches with renewable energy, Asia’s industrial sector is still heavily reliant on fossil fuels.
In other words, southeast Asia is the perfect market for companies like Apple. Unlike other areas like the US and China, this region hasn’t reached the “saturation point” of smart phone sales… which means a whole ot of growth is ahead.
Until next time,
A true insider in the technology and energy markets, Keith’s research has helped everyday investors capitalize from the rapid adoption of new technology trends and energy transitions. Keith connects with hundreds of thousands of readers as the Managing Editor of Energy & Capital, as well as the investment director of Angel Publishing’s Energy Investor and Technology and Opportunity.
For nearly two decades, Keith has been providing in-depth coverage of the hottest investment trends before they go mainstream — from the shale oil and gas boom in the United States to the red-hot EV revolution currently underway. Keith and his readers have banked hundreds of winning trades on the 5G rollout and on key advancements in robotics and AI technology.
Keith’s keen trading acumen and investment research also extend all the way into the complex biotech sector, where he and his readers take advantage of the newest and most groundbreaking medical therapies being developed by nearly 1,000 biotech companies. His network includes hundreds of experts, from M.D.s and Ph.D.s to lab scientists grinding out the latest medical technology and treatments. You can join his vast investment community and target the most profitable biotech stocks in Keith’s Topline Trader advisory newsletter.